The company has filed two IND for RP and RAO, Phas
Post# of 30028
Posted On: 12/22/2014 1:31:30 AM
The company has filed two IND for RP and RAO, Phase II for ESS and Eltoprazine. How much it would cost from IND to trial to FDA approval. It could easily be tens of millions if not hundreds of millions. Where this money is going to come from to facilitate trials.
The filing of these IND is indication that Lympro is primed to make huge revenues.
The filing of these IND is indication that Lympro is primed to make huge revenues.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼